We’re excited to announce that Berkeley Lights and IsoPlexis are moving forward together as PhenomeX, a premier functional cell biology company. Visit Site

News

ARTICLE: Broadly neutralizing antibodies target the coronavirus fusion peptide

News

The Pandemic Is Driving Innovative Microfluidic Disease Detection

News

Berkeley Lights and Bayer Announce Agreement to Spur Discovery of Next-Generation Traits

News

Mapping the Future of Cell Culture and Cell Line Development

News

Meet The Collaboration Solving Some Of Antibody Discovery’s Toughest Problems

News

Leveraging optofluidics to make therapeutic antibody discovery easier

News

Researchers pivot from COVID-19 response to preventing future pandemics

News

Military programs aiming to end pandemics forever

News

From Discovery To Delivery: Addressing Challenges in Cell Therapy

News

Biotech’s Brave New World: Bay Area startups band together to ramp up coronavirus research and testing

News

JP Morgan Healthcare Conference 2021, Day Two:Qiagen, Invitae, Agilent, Sema4, More

News

Finding the Best Cell for the Job

News

Pinpointing Bioprocess Development Success

News

Big Tech Is Under Pressure. Here’s Where to Find Growth

News

Berkeley Lights Helps Researchers Connect Genomic, Functional Characteristics of Cells

News

Soaring Biomedical IPOs Raise Questions About Money Left on the Table

News

Berkeley Lights Will Receive IPO of the Year Award at SynBioBeta 2020

News

Optofluidics Technology Accelerates Discovery of COVID-19 Treatments